G1 Therapeutics Inc (GTHX)
4.53
-0.15
(-3.21%)
USD |
NASDAQ |
May 17, 16:00
4.53
0.00 (0.00%)
After-Hours: 20:00
G1 Therapeutics Accounts Receivable (Quarterly): 11.65M for March 31, 2024
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 11.65M |
| December 31, 2023 | 12.69M |
| September 30, 2023 | 9.265M |
| June 30, 2023 | 11.87M |
| March 31, 2023 | 16.02M |
| December 31, 2022 | 11.09M |
| September 30, 2022 | 10.52M |
| June 30, 2022 | 10.79M |
| March 31, 2022 | 7.615M |
| Date | Value |
|---|---|
| December 31, 2021 | 5.688M |
| September 30, 2021 | 5.24M |
| June 30, 2021 | 4.962M |
| March 31, 2021 | 5.048M |
| December 31, 2020 | 0.237M |
| September 30, 2020 | |
| June 30, 2020 | |
| March 31, 2020 | |
| December 31, 2019 | 0.00 |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
Dec 2019
16.02M
Maximum
Mar 2023
8.180M
Average
9.265M
Median
Sep 2023
Accounts Receivable (Quarterly) Benchmarks
| Amicus Therapeutics Inc | 76.43M |
| Geron Corp | -- |
| Palatin Technologies Inc | 0.00 |
| Oragenics Inc | -- |
| TG Therapeutics Inc | 64.98M |